HALO
Halozyme Therapeutics, Inc.
$95.80−0.17 (−0.18%)Close Nov 18, 2026
Adjusted price
+36.66% total return, past year
Key statistics
- Market cap
- $10.9B
- P/E (TTM)
- 24.1
- 52-week range
- $61.63$131.18
- All-time high close
- $131.18 on Oct 29, 2026
- Beta (5Y monthly)
- 0.92
- Median dollar volume
- $229M
- Shares outstanding
- 114.0M
- Sector
- Health Care
- First close
- Mar 16, 2004
Returns
Total
- 1M
- −21.37%
- YTD
- +42.35%
- 1Y
- +36.66%
Per year
- 3Y
- +33.87%
- 5Y
- +22.03%
- 10Y
- +22.27%
- 20Y
- +19.58%
- Since 2004
- +14.73%